Literature DB >> 16324814

Identification and characterization of potential impurities of amlodipine maleate.

P Sudhakar1, M Nirmala, J Moses Babu, K Vyas, Ganta Madhusudan Reddy, B Vijaya Bhaskar, P Pratap Reddy, K Mukkanti.   

Abstract

Six impurities ranging from 0.43 to 1.42% in amlodipine maleate were detected by a simple isocratic reverse-phase high performance liquid chromatography (HPLC). LC-MS was performed to identify the mass of the impurities. Based on the spectral data (IR, NMR and MS), the structures of these impurities were characterized as 3-ethyl 5-methyl 4-(2-chlorophenyl)-2-[2-(1,3-dioxo-2,3-dihydro-1H-2-isoindolyl)ethoxymethyl]-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate (impurity I); 5-ethyl 3-methyl 4-(2-chlorophenyl)-2-methyl-6-[2-(2-methylcarbamoylphenyl-carboxamido)ethoxymethyl]-1,4-dihydro-3,5-pyridinedicarboxylate (impurity II); besylate salt of 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-3,5-pyridinedicarboxylate (impurity III); dimethyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinecarboxylate (impurity IV); 3-ethyl 5-methyl 2-(2-aminoethoxymethyl)-4-(4-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate (impurity V); diethyl 2-(2-aminoethoxymethyl)-4-(2-chlorophenyl)-6-methyl-1,4-dihydro-3,5-pyridinedicarboxylate (impurity VI).

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16324814     DOI: 10.1016/j.jpba.2005.10.029

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  3 in total

1.  Rapid simultaneous determination of telmisartan, amlodipine besylate and hydrochlorothiazide in a combined poly pill dosage form by stability-indicating ultra performance liquid chromatography.

Authors:  Santaji Nalwade; Vangala Ranga Reddy; Dantu Durga Rao; Inabathina Koteswara Rao
Journal:  Sci Pharm       Date:  2011-01-04

2.  Identification, synthesis and characterization of process related impurities of benidipine hydrochloride, stress-testing/stability studies and HPLC/UPLC method validations.

Authors:  Esen Bellur Atici; Bekir Karlığa
Journal:  J Pharm Anal       Date:  2015-02-13

3.  LC, MS n and LC-MS/MS studies for the characterization of degradation products of amlodipine.

Authors:  Ravi N Tiwari; Nishit Shah; Vikas Bhalani; Anand Mahajan
Journal:  J Pharm Anal       Date:  2014-08-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.